SINT Sintx Technologies, Inc.

$2.13 +5.72%

Healthcare · Surgical & Medical Instruments & Apparatus

Sintx Technologies, Inc. (SINT) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $9 million. Shares last traded at $2.13, 70.1% below their 52-week high. Over the past year the stock is down 25.3%. Net profit margin is -1018.1%, below the peer median of -7.6%. Revenue declined 64.7% year over year.

Market Cap

$9M

Shares Out

4.3M

EPS (TTM)

$-10.30

P/E Ratio

—

P/S Ratio

9.02

P/B Ratio

10.15

Dividend / Share

—

Dividend Yield

—

52-Week High

$7.11

52-Week Low

$1.80

Volume

256

Avg Vol (3m)

748.921

Performance

-3.63%

-4.92%

-24.24%

-39.46%

YTD

-42.72%

-25.31%

Chart

Full chart →

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)

45.64

SMA (50)

$2.36

SMA (200)

$3.25

Price vs SMA50

-10.02%

Price vs SMA200

-34.70%

ATR (14)

$0.13

Financials

Revenue

$1M

Net Income

$-10M

Gross Margin

45.3%

Operating Margin

-1053.1%

Net Margin

-1018.1%

Return on Equity

-1146.5%

Return on Assets

-132.7%

Current Ratio

1.04

Debt / Equity

0.01

Revenue Growth (YoY)

-64.7%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

Period	EPS (diluted)	Reported
Q1 2026	$-0.70	2026-05-15
FY 2025	$-6.16	2026-03-20
Q3 2025	$-6.17	2025-11-12
Q2 2025	$-2.14	2025-08-14
Q1 2026	$-1.29	2026-05-15
FY 2025	$-15.19	2026-03-20

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

SINT vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/S vs peers

9.02 / 2.52 med

+258% premium

Net margin vs peers

-1018.1% / -7.6% med

below median

1–14 of 14


SYK	Stryker Corporation	$118.1B	36.38	4.70	12.9%	+2.28%
MMM	3M	$83.9B	25.82	3.36	13.0%	+1.10%
BSX	Boston Scientific	$67.3B	23.27	3.35	14.4%	+0.64%
BDX	Becton Dickinson	$39.7B	23.64	1.82	7.7%	+1.62%
MDLN	Medline Inc.	$29.4B	—	—	—	-1.47%
DXCM	DexCom	$28.0B	33.43	6.00	17.9%	+1.69%
RMD	ResMed	$27.4B	19.53	5.32	27.2%	+1.24%
WST	West Pharmaceutical Services	$23.2B	46.92	7.54	16.1%	+1.35%
SOLV	Solventum	$13.1B	—	—	—	+1.21%
PEN	Penumbra Inc	$12.5B	70.18	8.88	12.7%	+0.28%
GMED	Globus Medical Inc	$10.8B	19.99	3.66	18.3%	+5.00%
BAX	Baxter International	$10.3B	-10.74	0.91	-8.5%	+2.58%
PODD	Insulet Corporation	$10.1B	40.84	3.73	9.1%	+1.51%
GKOS	Glaukos Corp	$7.7B	-40.92	15.13	-37.0%	+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.